
Sign up to save your podcasts
Or
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
5
77 ratings
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
1,058 Listeners
848 Listeners
3,483 Listeners
9,203 Listeners
7,765 Listeners
600 Listeners
500 Listeners
28,314 Listeners
191 Listeners
1,580 Listeners
26 Listeners
1,110 Listeners
2,700 Listeners
1,161 Listeners